Ticker: IRWD

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) has reported its financial results for the first quarter of 2025, revealing significant challenges in its operations amidst ongoing restructuring efforts. Key Points & Statistics: Collaborative Arrangements Revenue: Revenue decreased to $41.1 million...